Clinical Trial Update: Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]

View source ↗

Summary

Phase 3 efficacy study of Rezular (Arverapamil) for irritable bowel syndrome with diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Rezular (Arverapamil)

Snippet

Sponsor: AGI Therapeutics, Inc. | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 3 | Status: COMPLETED